Navigation Links
Pacira Pharmaceuticals, Inc. Announces EXPAREL™ Data Presentations at the International Anesthesia Research Society 2011 Annual Meeting
Date:5/23/2011

PARSIPPANY, N.J., May 23, 2011 /PRNewswire/ -- Pacira Pharmaceuticals, Inc., (Nasdaq: PCRX), an emerging specialty pharmaceutical company, today announced that clinical data highlighting the safety profile of EXPAREL™ (bupivacaine extended-release liposome injection) will be presented at the 2011 International Anesthesia Research Society (IARS) Annual Meeting in Vancouver, British Columbia.

Comprehensive, program-wide safety data for EXPAREL will be presented by Dr. Eugene R. Viscusi, Director, Acute Pain Management, Department of Anesthesiology, Jefferson Medical College, Thomas Jefferson University, on Monday, May 23, 2011 at 2:45 p.m. ET. Dr. Viscusi's presentation, titled "The Safety of EXPAREL™, A Multivesicular Liposomal Extended-Release Bupivacaine" examines the safety profile of EXPAREL in 823 patients across ten wound infiltration studies and five surgical procedures, including hemorrhoidectomy, bunionectomy, total knee arthroplasty, breast augmentation and hernia repair.

Pacira also announced that comprehensive, program-wide efficacy data for EXPAREL was highlighted at IARS. Dr. Sergio Bergese, associate professor of anesthesiology and neurological surgery, The Ohio State University, presented the poster, titled, "The Efficacy of EXPAREL™, A Multivesicular Liposomal Extended-Release Bupivacaine" on Sunday, May 22, 2011 at 8 a.m. ET. The poster was previously presented May 11, 2011 at the Society for Ambulatory Anesthesia (SAMBA) 26th Annual Meeting in San Antonio; this is the first time that the program wide efficacy and safety data have been presented together.

"We are excited to present these data, which support the utility of EXPAREL across multiple surgical models," said David Stack, president and chief executive officer of Pacira Pharmaceuticals. "While EXPAREL was well-tolerated across all doses, based upon clinical experience
'/>"/>

SOURCE Pacira Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Positive Phase II Study of Paciras EXPAREL(TM) (DepoBupivacaine) in Total Knee Arthroplasty Presented at International College of Surgeons World Congress
2. Positive Phase II Study of Paciras EXPAREL(TM) (DepoBupivacaine) in Hernia Repair Presented at the Postgraduate Assembly in Anesthesiology (PGA)
3. Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment
4. Pacira Pharmaceuticals Announces FDA Acceptance of EXPAREL™ New Drug Application for Pain Management
5. Pacira Pharmaceuticals Presents New Data from EXPAREL Phase 3 Study at Orthopaedic Research Societys 57th Annual Meeting
6. Pacira Pharmaceuticals, Inc. Announces Pricing of Its Initial Public Offering
7. Pacira Pharmaceuticals Highlights Additional Safety Data on EXPAREL™ for Postsurgical Pain Relief at 2011 American Academy of Orthopaedic Surgeons Annual Meeting
8. Pacira Pharmaceuticals EXPAREL™ Data to be Featured at 2011 ASCPT 112th Annual Meeting
9. Pacira Pharmaceuticals to Present at the Barclays Capital 2011 Global Healthcare Conference
10. Pacira Pharmaceuticals Reports Fourth Quarter and 2010 Financial Results
11. Pacira Pharmaceuticals to Present at BioCentury Future Leaders in the Biotech Industry Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... and NEW YORK and ... As the leading distributor of market intelligence, MarketResearch.com is ... report by IQ4I Research and Consultancy focusing on the ... more about IQ4I Research visit: http://www.marketresearch.com/land/publisher.asp?vendorid=4023&progid=86891 . ... Pharmaceutical Ingredients Global Market – Forecast to 2020 ...
(Date:11/26/2014)... 25, 2014  Medtronic,s roughly $43 billion ... widely discussed in the media for its US ... stronger leading player in one of the fastest ... healthcare market research firm said  the two companies ... diverse set of solutions spanning inpatient to home ...
(Date:11/26/2014)... Nov. 25, 2014  Breckenridge Pharmaceutical, Inc. announced ... ANDA agreement with Pii (Pharmaceutics International, Inc.) ( ... Breckenridge and Pii expect to develop and commercialize ... agreement, Pii will develop, manufacture and supply the ... products under its own label.  The drugs, comprised ...
Breaking Medicine Technology:MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 2MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 3Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 2Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 3Breckenridge Pharmaceutical signs Multi-Product Generic Agreement with Pharmaceutics International, Inc. 2
... CHICAGO, Sept. 10 Celsis In Vitro, Inc. (Celsis ... for the Northern District of Illinois in Chicago has ... and Life Technologies (the Defendants) due to their infringement ... Technologies of Carlsbad, California (Nasdaq: LIFE ) ...
... eResearchTechnology, Inc. (ERT), (Nasdaq: ERES ), ... pharmaceutical, biotechnology, and medical device industries, today announced that ... President and Chief Executive Officer and a director of ... search for a successor.  Dr. McKelvey will continue in ...
Cached Medicine Technology:Celsis IVT Wins Preliminary Injunction Against Life Technologies and CellzDirect in Liverpool™ Patent Infringement Lawsuit 2Celsis IVT Wins Preliminary Injunction Against Life Technologies and CellzDirect in Liverpool™ Patent Infringement Lawsuit 3ERT Announces Upcoming Retirement of Michael McKelvey as Chief Executive Officer 2ERT Announces Upcoming Retirement of Michael McKelvey as Chief Executive Officer 3
(Date:11/27/2014)... 2014 RBSEO Services, a well-established ... optimization service just at $99. RBSEO Services knows ... afford costly search engine optimization service. So, the ... affordablity and requirements into consideration. , The ... has not compromised with the service quality. The ...
(Date:11/27/2014)... CA, (PRWEB) November 26, 2014 ... browser-based presentation platform, focused on increasing audience engagement ... Britannic Technologies. Lintelus’ software platform includes a multitude ... and presenter in a collaborative, interactive multi-screen environment. ... and the presentation in real time on their ...
(Date:11/26/2014)... (PRWEB) November 26, 2014 Dr. Parsa ... themselves this holiday season! With Parsa Mohebi Hair Restoration’s ... off of their next FUE procedure, making it that ... FUE—which stands for “Follicular Unit Extraction”—is an advanced variety ... traditional “strip” Follicular Unit Transplantation (FUT). FUE, unlike FUT, ...
(Date:11/26/2014)... iFitDress.com, a well-known wedding dress manufacturer ... sweet 16 cocktail dresses . Included in the new ... Furthermore, all of these charming outfits are offered at ... company has promised that all of the sweet 16 ... is worth mentioning that all of them are set ...
(Date:11/26/2014)... By Alex Kramer ... -- People with rheumatoid arthritis may be more likely to ... to new research. The study found that those who ... remission. Being underweight also lowered the odds of remission. ... overweight population," said Dr. Susan Goodman, the study,s lead author ...
Breaking Medicine News(10 mins):Health News:RBSEO Services Announces SEO Services at $99 Only 2Health News:Lintelus Showcases its Feature-Rich Presentation Technology Solution at Convergence Summit’s Annual Event in London 2Health News:FUE Special at Parsa Mohebi Hair Restoration This Holiday Season 2Health News:iFitDress.com: Trendy Sweet 16 Cocktail Dresses Unveiled 2Health News:Weight Could Influence Rheumatoid Arthritis Relief 2Health News:Weight Could Influence Rheumatoid Arthritis Relief 3
... ... Association (AWWA) is urging students and job seekers to explore the water sector to discover ... rewarding. , ... May 4, 2010 -- As Drinking Water Week continues, the American Water Works Association ...
... VANCOUVER, BRITISH COLUMBIA Adolescents who don,t get enough ... play video games or text their friends. They also ... May 4 at the Pediatric Academic Societies (PAS) annual ... have shown a relationship between sleep and weight issues, ...
... ... use competitive intelligence data to develop actionable marketing strategies with the help of Evolve Creative ... ... marketing and design firm, now offers businesses in Hamilton a competitive intelligence analysis ...
... The Carrousel Yacht ... Florida. Renowned for its award-winning gourmet cuisine, the Carrousel Yacht is a boutique operation providing ... by Great Bay Yacht Charters and has been in the hospitality industry and yacht charter ... ...
... enzyme deficiency disorder, is one of many conditions with few ... today in Blood , the journal of the American ... II clinical trial of eliglustat tartrate, an oral therapy in ... genetic disorder affecting an estimated 1 in 50,000 to 1 ...
... a specific type of dopamine receptor gene respond ... without the genotype, according to new research from ... come from the first-ever placebo-controlled pharmacogenetic drug trial ... to evaluate variants of the DRD4 dopamine receptor ...
Cached Medicine News:Health News:During Drinking Water Week 2010, Water Sector Urges Students, Job Seekers to Work for Water 2Health News:Less sleep may add up to more pounds in adolescents 2Health News:Evolve Creative Media Offers Competitive Market Analysis to Assist Small Businesses in Hamilton 2Health News:Carrousel Yacht: Miami Private Yacht Charters With Style, Taste and Value 2Health News:Carrousel Yacht: Miami Private Yacht Charters With Style, Taste and Value 3Health News:Phase II study of an oral therapy for Gaucher disease yields positive results 2Health News:Research helps end guesswork in prescribing ADHD drug 2
... series SV stereomicroscopes are ... type. Thanks to their ... optimally adapt to the ... is an advantage which ...
A compact stereomicroscope that is immediately ready for operation and extremely easy to use. Focused on the essential performance features, the Stemi DV4 design concept provides optimum utility....
6.3X Zoom Ratio - Boasting magnifications from 0.8X to 5X, the twin zooming objective optical system developed exclusively by Nikon provides a zoom ratio of 6.3:1. Clickstops at 1X intervals allow ob...
... Fluor 20x Water Dipping Objective is ... research where the objective is actually ... or brain slice. The objective provides ... with a numberical aperature of 0.50, ...
Medicine Products: